We’re honored to be ranked #8 on CNBC's #Disruptor50 list, marking our third recognition in four years. It’s a privilege to advance the future of cell and gene therapy. Hear what being a disruptor means to Emyline (Emmy) Lumasag, our People Experience Specialist II:
ElevateBio
Biotechnology Research
Waltham, Massachusetts 32,381 followers
A cell and gene therapy company accelerating access to technologies and expertise to change the future of medicine.
About us
ElevateBio is a technology-driven company built to power transformative genetic medicines today and for many decades to come. The Company commercializes its enabling technologies, manufacturing capabilities, and industry-leading expertise through partnerships to accelerate development across a breadth of therapeutic approaches and modalities. The ElevateBio ecosystem combines multiple R&D technology platforms – including Life Edit, a next-generation, full-spectrum gene editing platform; comprehensive cell engineering technologies; and an expanded viral and non-viral therapeutic delivery platform – with BaseCamp®, its end-to-end genetic medicine cGMP manufacturing and process development business, to accelerate the discovery and development of advanced therapeutics. ElevateBio aims to be the dominant engine inside the world’s greatest scientific advancements harnessing human cells and genes to alter disease.
- Website
-
https://www.elevate.bio/
External link for ElevateBio
- Industry
- Biotechnology Research
- Company size
- 201-500 employees
- Headquarters
- Waltham, Massachusetts
- Type
- Privately Held
- Specialties
- cell therapy, gene therapy, and cell and gene therapy
Locations
-
Primary
Get directions
200 Smith St
Waltham, Massachusetts 02451, US
Employees at ElevateBio
Updates
-
We are leveraging artificial intelligence (AI) to accelerate the discovery and design of CRISPR systems to propel us closer to our promise of developing therapeutic options for patients in need. #AI #ElevateBio #CRISPR
-
-
We're excited to share the progress of ElevateBio’s new BaseCamp Pittsburgh biomanufacturing facility built in partnership with the University of Pittsburgh and the Richard King Mellon Foundation. Discover how BaseCamp Pittsburgh will bring technologies, expertise, operations, processes, manufacturing, and workforce development to a city ready to participate in this growing life sciences industry and be a part of the development and commercialization of transformative therapies.
-
Congratulations to our partner Abata Therapeutics on this terrific achievement! We’re proud to work with Abata, leveraging our manufacturing and process development capabilities at BaseCamp and our LentiPeak™ lentiviral vector technology platform to advance this program and bring potentially transformative therapies to patients in need.
We’re excited to announce IND clearance of ABA-101 for Progressive Multiple Sclerosis (MS). It’s the first open IND for our best-in-class autologous TCR-Treg cell therapy platform. We expect to initiate our Phase 1 study later this year. This is an important milestone for us and for patients. ABA-101 was specifically designed to benefit Progressive MS patients who have no or insufficient treatment options today. bit.ly/3LiotOa
-
-
We're excited to welcome our 2024 Summer Intern & Co-Op class! Hear what a few of our innovators look forward to learning at ElevateBio and Life Edit Therapeutics. We’re proud to mentor and educate students in transforming the future of medicine. #ElevateBio #Internship #CellAndGeneTherapy
-
An efficient technology transfer is vital to the production and development of genetic medicines. By partnering with us at ElevateBio, you’re ensuring a fast, consistent, and cost-effective technology integration of knowledge, processes, specifications, and data into BaseCamp. Learn how we can help accelerate production and safeguard your timelines: https://lnkd.in/gxPGzREJ. #ElevateBio #GeneTherapy
-
-
Today, we celebrate freedom–to innovate, to explore, and to embark on our culture of expedition toward groundbreaking therapies. Have a safe and happy Independence Day! #4thOfJuly
-
-
We'll be presenting at the Global Cell & Gene Therapy Summit in Boston! Join Supriya Prakash, Ph.D., Scientist I, Cellular Process Development, for "Low Volume Wash, Formulation and Fill Strategies for T Cell Therapies" (CGT-7) on July 9. For additional details, visit https://cgtsummit.com/. We look forward to networking with you! #CellAndGeneTherapy
-
-
Our novel lipid nanoparticles (LNP) platform has both liver targeting and de-targeting potential, enhancing our ability to effectively deliver gene therapies and unlocking new possibilities for addressing a wide range of diseases and disorders. Discover our platform’s potential and delivery capabilities at https://lnkd.in/e8PRHJnj. #ElevateBio #GeneEditing
-
-
Pride Month is a time to celebrate the LGBTQ+ community and equality. At our 2nd Annual Smith Street Pride Party, co-hosted with Boston Dynamics and Deciphera Pharmaceuticals. Our teammates enjoyed various activities, including a raffle benefiting The Trevor Project, a leading nonprofit for LGBTQ youth suicide prevention. At ElevateBio, diversity, equity, and inclusion are fundamental to our values. "Respect Perspective" highlights the importance of honoring each teammate's unique voice and experience. #ElevateBio #Pride
-